The significance is structural: IBM is not eliminating “underperforming units” but dismantling entire human layers in favor ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

I no longer rely on my router’s DNS service after I started using Unbound on my home network. After setting up split-horizon DNS for internal subnets at home, I used public DNS servers for the ...

"The more that I could understand not just the business, but also how the business thought about its success, how the business thought about impact, the better lawyer I would be," said Tinu Diver, ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) shares are volatile on Tuesday following the release of the company’s second-quarter financial results. Here’s what you need to know. RXRX is hovering near ...

The Permutation Generator lab currently requires people to create a recursive function to form an array of possible permutations of a string. But the way it wants that to happen seems to be very ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $5.03, moving -6.85% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.52%.

Shares of Recursion Pharmaceuticals (NASDAQ:RXRX) traded higher in the premarket on Tuesday after the AI-driven biotech announced plans to reduce its workforce by approximately 20% as part of a ...